Strategic Partnerships Position NantWorks and ImmunityBio for collaboration with global biotech hubs and government-backed vaccine initiatives, leveraging past SA national manufacturing initiatives and U.S.-Saudi Biotech Alliance Summit participation to propose joint development and manufacturing programs.

Vaccines and Immunotherapy Capitalize on ongoing vaccine and cancer immunotherapy platforms to offer integrated R&D services, clinical development support, and manufacturing capacity partnerships targeting high-demand infectious disease and oncology markets.

Advanced Tech Services Offer analytics and AI-driven bioprocess optimization, bioinformatics, and data management services leveraging NantWorks’ ecosystem to improve R&D throughput, accuracy, and scale for partner organizations.

Manufacturing Capacity Highlight potential turnkey manufacturing partnerships or contract manufacturing capabilities to support scale-up, given the plan to produce up to one billion vaccines annually and related cell-based therapies.

IP and Patents Address opportunities around AR/AI-enabled clinical tools and precision medicine platforms by proposing licensing deals, collaboration on patent-rich technology, and risk-managed joint ventures with a focus on competitive differentiation.